Souhaitez-vous accéder aux communiqués récents ?

DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced its partnership with U.S. Neurology Associates (“USNA” or...

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "AI in Neurology: Global Markets" has been added to ResearchAndMarkets.com's offering. The global AI in neurology market is quickly expanding, with...

Paris, Jan. 06, 2026 (GLOBE NEWSWIRE) -- 88% reduction in urinary incontinence episodes in patients with neurogenic bladder sustained through 24 weeksGood tolerability maintainedEnrollment and...

The global market for brain tumor therapeutics was valued at $2.5 billion in 2024 and is projected to reach $4.7 billion by the end of 2030.

COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE UNE NOUVELLE PUBLICATION SUR MEDRXIV METTANT EN ÉVIDENCE LE BÉNÉFICE CLINIQUE DU MASITINIB CHEZ LES PATIENTS ATTEINTS DE SCLÉROSE LATÉRALE AMYOTROPHIQUE AVANT...

PRESS RELEASE AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTION Significant...

Vertero appointed 5 globally recognized leaders to its Scientific Advisory Board, strengthening the company’s mission to advance innovative therapies.

MMI today announced that it received U.S. Food and Drug Administration 510(k) clearance for its NanoWrist® Scissors and Forceps indicated for soft tissue.

Vertero appoints Jeffrey Kasten as Chief Business Officer to drive strategic partnerships and accelerate portfolio strategy in neurodegenerative diseases.

Longeveron granted Canadian patent for method of using stem cells to treat patients with aging-related frailty and also for the treatment of NIDCM.